Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.

Communicable disease and public health / PHLS

Volumn 5, Issue 3, 2002, Pages 220-225

  Trotter, C L ^a   Ramsay, M E ^a   Kaczmarski, E B ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MALE; MASS IMMUNIZATION; MENINGOCOCCOSIS; MIDDLE AGED; MORTALITY; NEISSERIA MENINGITIDIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MASS IMMUNIZATION; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP C; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME; WALES;

EID: 0036725028     PISSN: 14621843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)